Health Condition 1: null- Patients scheduled to undergo leino-renal shunt surgery
Conditions
Interventions
Intervention1: Intervention Group T - continuous TAP block group: A continuous TAP block in the first 24 hrs postoperatively with a bolus of 20 ml of 0.375% ropivacaine followed by continuous infusi
Sponsors
All India Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: ASA I-III patients of age > 18years, undergoing LR shunt surgery will be enrolled in the study
Exclusion criteria
Exclusion criteria: • Patient refusal • Age • Emergency surgery, • Known hypersensitivity to local anaesthetics • Chronic pain conditions • History of drug abuse • Inability to understand VAS or PCA functioning • Severe renal or liver dysfunction • Morbid obesity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intravenous patient controlled analgesia(IV PCA) morphine consumptionTimepoint: 24 hrs postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications or adverse effects such as bleeding/hematoma formation, infection, or local anaesthetic toxicityTimepoint: 24 hrs after surgery;Incidence of opioid related side-effects (nausea/vomiting, sedation, respiratory depression, postoperative ileus)Timepoint: 24 hrs after surgery;Patient satisfaction with the quality of postoperative analgesiaTimepoint: 24 hours after the end of surgery;Postoperative visual analog scale (VAS) scores at rest and on coughingTimepoint: 1, 2, 6, 12, 24, 48, and 72 hours after surgery;Time to first requirement of analgesic doseTimepoint: After the end of surgery | — |
Countries
India
Contacts
Public ContactVimi Rewari
All India Institute of Medical Sciences,New Delhi
Outcome results
None listed